Stem cells and neurodegenerative diseases

被引:14
作者
Hou LingLing [1 ]
Hong Tao [1 ]
机构
[1] Beijing Jiaotong Univ, Inst Biol Sci & Technol, Beijing 100044, Peoples R China
来源
SCIENCE IN CHINA SERIES C-LIFE SCIENCES | 2008年 / 51卷 / 04期
关键词
stem cells; neurodegenerative diseases; therapy;
D O I
10.1007/s11427-008-0049-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurodegenerative diseases are characterized by the neurodegenerative changes or apoptosis of neurons involved in networks, which are important to specific physiological functions. With the development of old-aging society, the incidence of neurodegenerative diseases is on the increase. However, it is difficult to diagnose for most of neurodegenerative diseases. At present, there are too few effective therapies. Advances in stem cell biology have raised the hope and possibility for the therapy of neurodegenerative diseases. Recently, stem cells have been widely attempted to treat neurodegenerative diseases of animal model. Here we review the progress and prospects of various stem cells, including embryonic stem cells, mesenchymal stem cell and neural stem cells and so on, for the treatments of neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, Huntington' disease and Amyotrophic lateral sclerosis/Lou Gehrig's disease.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 54 条
[1]   Alzheimer's disease and the basal forebrain cholinergic system:: relations to β-amyloid peptides, cognition, and treatment strategies [J].
Auld, DS ;
Kornecook, TJ ;
Bastianetto, S ;
Quirion, R .
PROGRESS IN NEUROBIOLOGY, 2002, 68 (03) :209-245
[2]   Effect of fetal neural transplants inpatients with Huntington's disease 6 years after surgery:: a long-term follow-up study [J].
Bachoud-Lévi, AC ;
Gaura, V ;
Brugières, P ;
Lefaucheur, JP ;
Boissé, MF ;
Maison, P ;
Baudic, S ;
Ribeiro, MJ ;
Bourdet, C ;
Remy, P ;
Cesaro, P ;
Hantraye, P ;
Peschanski, M .
LANCET NEUROLOGY, 2006, 5 (04) :303-309
[3]   Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model [J].
Björklund, LM ;
Sánchez-Pernaute, R ;
Chung, SM ;
Andersson, T ;
Chen, IYC ;
McNaught, KS ;
Brownell, AL ;
Jenkins, BG ;
Wahlestedt, C ;
Kim, KS ;
Isacson, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2344-2349
[4]   Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: A return to control measures [J].
Bjugstad, KB ;
Redmond, DE ;
Teng, YD ;
Elsworth, JD ;
Roth, RH ;
Blanchard, BC ;
Snyder, EY ;
Sladek, JR .
CELL TRANSPLANTATION, 2005, 14 (04) :183-192
[5]  
Chen Chun-Wei David, 2006, Current Alzheimer Research, V3, P63, DOI 10.2174/156720506775697205
[6]   Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis [J].
Crigler, L ;
Robey, RC ;
Asawachaicharn, A ;
Gaupp, D ;
Phinney, DG .
EXPERIMENTAL NEUROLOGY, 2006, 198 (01) :54-64
[7]  
Ende Norman, 2001, Journal of Medicine (Westbury), V32, P241
[8]   Transplantation of embryonic dopamine neurons for severe Parkinson's disease. [J].
Freed, CR ;
Greene, PE ;
Breeze, RE ;
Tsai, WY ;
DuMouchel, W ;
Kao, R ;
Dillon, S ;
Winfield, H ;
Culver, S ;
Trojanowski, JQ ;
Eidelberg, D ;
Fahn, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :710-719
[9]   DEVELOPMENT OF THE HUMAN STRIATUM - IMPLICATIONS FOR FETAL STRIATAL TRANSPLANTATION IN THE TREATMENT OF HUNTINGTONS-DISEASE [J].
FREEMAN, TB ;
SANBERG, PR ;
ISACSON, O .
CELL TRANSPLANTATION, 1995, 4 (06) :539-545
[10]   Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for parkinsonism [J].
Fu, YS ;
Cheng, YC ;
Lin, MYA ;
Cheng, H ;
Chu, PM ;
Chou, SC ;
Shih, YH ;
Ko, MH ;
Sung, MS .
STEM CELLS, 2006, 24 (01) :115-124